Overview

A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery

Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-12
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, safety, and tolerability of bupivacaine liposomes for paravertebral nerve block in the treatment of thoracoscopic postoperative pain, and to evaluate the relevant human pharmacokinetics.
Phase:
PHASE2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Bupivacaine